Alpha Level vs. Beta Level

In the architecture of modern empirical science, inferential statistics serves as the mathematical scaffolding enabling researchers to transcend the boundaries of observed sample data and articulate generalizable claims regarding unobserved population parameters. Every scientific discovery, clinical breakthrough, epidemiological intervention, and technological innovation validated through experimental inquiry rests upon a probabilistic foundation. Because empirical researchers rarely possess the omniscient luxury of exhaustive population censuses, they are fundamentally condemned to operate in an environment characterized by pervasive uncertainty and stochastic variability. The inferential bridge connecting finite, noisy sample measurements to transcendent population truths is therefore intrinsically vulnerable to error. To formalize, quantify, and govern these unavoidable vulnerabilities, mathematical statisticians developed the framework of statistical hypothesis testing, within which two foundational parameters dictate the epistemic boundaries of scientific discovery: the alpha level (α) and the beta level (β).

The alpha level and the beta level delineate the two primary vectors of inferential failure that plague quantitative inquiry. The alpha level, conventionally synonymous with the threshold for establishing statistical significance, dictates the probability of committing a Type I error: the erroneous rejection of a true null hypothesis, colloquially recognized as declaring a false positive or raising a false alarm. Conversely, the beta level quantifies the probability of committing a Type II error: the failure to reject a false null hypothesis in the presence of an authentic underlying population effect, colloquially understood as a false negative or a missed discovery. Statistical power, defined mathematically as the complement of the beta level (1 − β), quantifies an experiment’s sensitivity and its operative capacity to detect genuine empirical phenomena when they truly exist.

Although these two parameters occupy complementary roles within the classical decision-theoretic architecture formalized by Jerzy Neyman and Egon Pearson, their operational treatments within contemporary scientific practice are marked by a profound and problematic asymmetry. While the alpha level has historically been elevated to the role of an absolute epistemic gatekeeper—reified through ubiquitous conventions such as the canonical p < .05 threshold—the beta level has frequently been relegated to an afterthought, resulting in a systemic prevalence of underpowered studies across the biomedical, psychological, and behavioral sciences. This comprehensive treatise provides an exhaustive, mathematically rigorous, and methodologically thorough comparative analysis of the alpha level and the beta level. Across the following sections, we dissect their theoretical origins, mathematical formulations, operational divergences, hydraulic trade-offs, and domain-specific optimizations, establishing a formal decision framework for balanced, robust, and reproducible scientific inference.

1. Introduction to Hypothesis Testing Errors: Alpha vs. Beta

1.1 Foundations of Inferential Decision-Making

The conceptual framework underpinning contemporary quantitative hypothesis testing represents an intellectual synthesis—and occasional uneasy amalgamation—of two fundamentally distinct paradigms: the significance testing paradigm pioneered by Sir Ronald A. Fisher and the behavioral decision theory formulated by Jerzy Neyman and Egon S. Pearson (1933). Fisher conceived of the p-value as a continuous, post-experimental inductive metric that reflected the strength of evidence against an isolated null hypothesis (H₀). In Fisher’s conceptual universe, a small p-value indicated that the observed sample data, or data more extreme, would be exceedingly improbable if the null hypothesis of no effect were strictly true, thereby prompting the investigator to doubt the validity of the null premise. Fisher did not formalize an explicit, alternate hypothesis distribution, nor did he conceptualize an operational machinery designed for automated binary actions.

In contrast, Neyman and Pearson radically reformulated inferential testing into an explicit, rule-governed mathematical decision framework. They argued that an investigator cannot evaluate the plausibility of a hypothesis in isolation; rather, a statistical test must choose between at least two competing, mathematically defined hypotheses: a null hypothesis (H₀) and an alternative hypothesis (H₁). In the Neyman-Pearson paradigm, statistical testing is not an inductive exercise in measuring subjective epistemic belief, but a prospective, deductive mechanism designed to govern long-run behavioral decisions. The researcher establishes an operational decision rule prior to data collection, partitioning the sample space into an acceptance region and a critical rejection region. Upon observing the empirical data, the researcher executes one of two deterministic actions: either reject H₀ in favor of H₁, or fail to reject H₀.

Because sample statistics are subject to random sampling fluctuations, no finite sample can offer absolute certainty regarding population parameters. The sampling distribution of any test statistic (such as a t-statistic, z-score, or F-ratio) under the assumption that H₀ is true exhibits dispersion governed by the central limit theorem and the variance of the underlying population. Similarly, if an alternative hypothesis H₁ is true with a specified non-zero effect size, the test statistic follows a non-central sampling distribution shifted along the horizontal axis. Because these two distributions invariably overlap across real-valued parameter spaces, any fixed critical threshold dividing the sample space partitions both distributions simultaneously. This fundamental reality introduces two distinct, unavoidable failure modes:

• Type I Error (False Alarm / Alpha): The data fall into the critical rejection region even though H₀ is entirely true. The investigator concludes that an experimental intervention has produced a genuine effect, when in reality the observed deviation reflects nothing more than stochastic sampling noise.
• Type II Error (Missed Discovery / Beta): The data fall into the non-rejection region even though H₁ is true and an authentic population effect exists. The investigator fails to reject the null hypothesis, mistakenly treating a real, substantive phenomenon as indistinguishable from background noise.

Navigating inferential decision-making requires managing these probabilistic hazards. Science does not proceed by infallible leaps; it progresses through the deliberate, mathematical regulation of error rates over repeated iterations of empirical inquiry. In this probabilistic landscape, alpha and beta serve as the primary mathematical dials through which the scientific community calibrates its institutional tolerance for false assertions versus blind omissions.

1.2 Why Alpha and Beta Are Continuously Compared and Confused

The comparative juxtaposition of alpha and beta is a natural consequence of their structural symmetry within the classical 2 × 2 inferential decision matrix. In this matrix, nature establishes an objective, unobserved state of reality (either H₀ is true or H₁ is true), while the empirical investigator renders a categorical verdict (reject H₀ or fail to reject H₀). This crossing generates four distinct operational outcomes: two correct decisions (correctly failing to reject a true null hypothesis with probability 1 − α, and correctly rejecting a false null hypothesis with probability 1 − β, termed statistical power), and two catastrophic errors (Type I error with probability α, and Type II error with probability β). Because they mirror one another across the diagonal of this matrix, researchers frequently treat them as conceptually interchangeable dials, leading to severe cognitive and methodological confusion.

One of the most persistent confusions in quantitative pedagogy and applied research is the conflation between the pre-specified alpha level (α), the empirical p-value, and the beta level (β). Practitioners often conflate the probability of an error occurring given a specific state of nature with the inverse conditional probability of nature given a statistical verdict. For instance, researchers commonly fall prey to the inverse probability fallacy, mistakenly interpreting α = .05 as meaning that there is only a 5% chance that a rejected null hypothesis is actually true (an erroneous posterior probability, P(H₀ | Reject)), or assuming that β = .20 implies an 80% posterior probability that an accepted null hypothesis is accurate. In truth, α and β are strictly forward-looking sampling probabilities conditioned entirely upon assumed population realities: α = P(Reject H₀ | H₀ is true), and β = P(Fail to Reject H₀ | H₁ is true).

A second major source of confusion lies in the failure to recognize the hydraulic, inverse trade-off dynamic that governs alpha and beta under fixed experimental conditions. Because the critical threshold that delineates the rejection region under the null distribution simultaneously serves as the boundary for the non-rejection region under the alternative distribution, moving the threshold to suppress one error directly inflates the other. If an investigator decides to dramatically reduce α from .05 to .001 to prevent false alarms, the critical cutoff moves further into the tail of the null distribution. Assuming the sample size (N) and the true effect size remain constant, this shift automatically sweeps a substantially larger proportion of the alternative distribution into the non-rejection zone, causing β to escalate rapidly and statistical power to collapse. Researchers who fail to grasp this mathematical coupling frequently establish unrealistically conservative alpha thresholds without realizing that they are simultaneously guaranteeing an overwhelmingly high rate of missed discoveries.

2. Comprehensive Overview of Alpha Level

2.1 Mathematical Definition and Type I Error

The alpha level (α), frequently designated as the nominal significance level of a statistical test, represents the maximum allowable probability of committing a Type I error within the Neyman-Pearson framework. Formally, let X represent a vector of observed sample data drawn from a sample space Ω, and let T(X) denote a test statistic whose probability density function under the null hypothesis H₀: θ = θ₀ is given by f(t | θ₀). The decision rule partitions the sample space into a critical region C (the rejection region) and a complementary non-critical region C^c. The mathematical definition of the alpha level is expressed as the conditional probability:

α = P(T(X) ∈ C | H₀ is true) = ∫_C f(t | θ₀) dt

In this formulation, α is a fixed, prospective parameter established by the researcher prior to the inspection of the empirical data. It dictates the precise physical boundary of the critical region C along the test statistic’s reference distribution. For example, in a standard two-tailed continuous Gaussian test where the test statistic follows a standard normal distribution under the null hypothesis, Z ~ N(0, 1), an alpha level of α = .05 dictates that the critical region comprises all values of Z such that |Z| ≥ z_{1 − α/2} = 1.95996. If the calculated sample statistic falls within this extreme 5% tail area, the null hypothesis is categorically rejected.

Crucially, a sharp theoretical boundary must be maintained between the pre-specified nominal alpha level (α) and the empirical p-value generated from the collected data. The p-value is a random variable that varies from sample to sample, defined as the conditional probability, calculated under the assumption that H₀ is strictly true, of obtaining a test statistic at least as extreme as the quantity observed in the actual experiment: p = P(|T| ≥ |t_obs| | H₀). The alpha level is the fixed structural yardstick; the p-value is the empirical realization. The Neyman-Pearson decision protocol is purely binary: if p ≤ α, the result is declared statistically significant and H₀ is rejected; if p > α, the result fails to achieve significance and H₀ is retained. The alpha level represents the long-run frequency of false rejections that an investigator is prepared to tolerate across an infinite sequence of identical experiments in which the null hypothesis is universally true.

2.2 Standard Conventions and Justifications

The ubiquitous entrenchment of α = .05 as the standard demarcation of statistical significance traces its historical lineage directly to the foundational writings of Sir Ronald A. Fisher, most notably in his seminal 1925 text, Statistical Methods for Research Workers. Fisher observed that a deviation exceeding two standard deviations from the mean in a normal distribution occurs by chance roughly once in every twenty trials (a probability of approximately .0455, rounded to .05). Fisher proposed that an event occurring less than once in twenty trials represented a convenient practical standard for an investigator to suspect that the phenomenon under examination was not entirely attributable to chance. Fisher never intended for α = .05 to become a rigid, unyielding dogma; rather, he viewed it as a fluid, informal threshold to guide the scientific investigator’s personal skepticism. However, as statistical training became institutionalized throughout the mid-twentieth century, Fisher’s pragmatic rule of thumb solidified into an inflexible bureaucratic standard governing academic publication across psychology, medicine, ecology, and the social sciences.

Despite the pervasive hegemony of the .05 benchmark, various scientific disciplines operating under different operational risk profiles have established drastically divergent alpha conventions. In confirmatory pharmaceutical trials submitted to regulatory agencies such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA), an alpha level of .01 or two independent replications at α = .025 (one-sided) are frequently mandated to ensure drug efficacy is demonstrated beyond reasonable doubt before a compound is released to millions of patients. In high-energy particle physics, where billions of stochastic subatomic collisions generate vast volumes of background noise, the discipline rejects the .05 standard entirely, enforcing an extraordinary “5-sigma” threshold for claiming a definitive discovery. A 5-sigma criterion corresponds to an alpha level of approximately α = 2.87 × 10⁻⁷ (one-tailed), a stringency explicitly designed to prevent the physics community from prematurely declaring the discovery of hypothetical particles, such as the Higgs Boson, based on stochastic anomalies.

Furthermore, when empirical investigations entail the simultaneous evaluation of multiple hypotheses, the cumulative family-wise Type I error rate across the entire battery of tests escalates rapidly according to the formula α_family = 1 − (1 − α)^k, where k represents the number of independent hypotheses tested. To preserve nominal alpha control across multi-testing architectures, researchers must implement mathematical corrections. The classical Bonferroni adjustment establishes a per-comparison alpha of α_corrected = α / k, maintaining strict control over the family-wise error rate at the cost of immense statistical conservatism. More sophisticated sequentially rejective techniques, such as the Holm-Bonferroni method, or error-rate alternatives like the False Discovery Rate (FDR) developed by Yoav Benjamini and Yosef Hochberg (1995), regulate the expected proportion of false rejections among all rejected hypotheses, establishing a viable balance in large-scale data environments such as microarrays and whole-genome sequencing.

2.3 Practical Implications of Alpha Selection

The selection of an alpha level exerts profound real-world consequences on the reliability, cumulative integrity, and economic trajectory of scientific research. When an alpha level is set too leniently (e.g., α = .10 or .15 in non-exploratory contexts), the scientific ecosystem becomes inundated with Type I errors. In this regime, investigators publish false discoveries that fail to replicate in subsequent independent trials. This dynamic lies at the epistemic core of the contemporary “replication crisis” documented across psychology, oncology, and behavioral economics. As demonstrated in the mathematical modeling of John P. A. Ioannidis (2005), when empirical fields operate with standard alpha levels of .05, low pre-study odds of genuine relationships, and widespread publication bias favoring positive results, the positive predictive value of research findings collapses, resulting in a condition where “most published research findings are false.”

Conversely, the reflexive imposition of excessively conservative alpha thresholds (such as unilaterally adopting α = .005 or .001 across all empirical domains, as proposed by some reform movements) induces its own devastating scientific pathologies. When an alpha threshold is throttled downward without a compensatory, orders-of-magnitude expansion in sample size (N), the statistical power of experiments to detect subtle, genuine effects is obliterated. Under such hyper-skeptical conditions, valid, innovative discoveries are suppressed at their inception. Promising therapeutic molecules capable of alleviating chronic human suffering may be summarily abandoned during early preclinical trials simply because their sample effects fall short of an arbitrary, hyper-conservative significance line.

Ultimately, the alpha level acts as the scientific community’s macroscopic regulatory valve controlling the influx of new theoretical claims into the published literature. Lowering the alpha threshold clears the scientific landscape of transient false alarms, but it erects an immense barrier to entry that can enforce intellectual stagnation, favor established institutional paradigms, and severely penalize research conducted on rare diseases or hard-to-reach human populations where acquiring massive sample sizes is logistically impossible. The selection of an alpha level is therefore not merely an abstract mathematical convenience; it is an active value judgment balancing epistemic skepticism against empirical discovery.

3. Comprehensive Overview of Beta Level

3.1 Mathematical Definition and Type II Error

The beta level (β) represents the probability of committing a Type II error within the Neyman-Pearson decision architecture. A Type II error occurs when an empirical test fails to reject the null hypothesis H₀ despite the circumstance that H₀ is false, meaning that a specific alternative hypothesis H₁ represents the authentic state of nature. While the alpha level can be evaluated directly against a singular point null hypothesis (e.g., H₀: μ₁ − μ₂ = 0), the calculation of the beta level is fundamentally dependent upon specifying a particular, non-zero alternative population parameter (θ₁ ≠ θ₀). Formally, let f(t | θ₁) denote the non-central probability density distribution of the test statistic under the specific alternative parameter θ₁. The mathematical definition of beta is expressed as:

β = P(T(X) ∉ C | H₁(θ₁) is true) = ∫_C^c f(t | θ₁) dt

Where C^c represents the complement of the critical region (the acceptance or non-rejection region) established by the pre-selected alpha threshold. In physical terms, beta corresponds to the integral of the alternative hypothesis’s sampling distribution that falls within the non-significant boundaries defined by the null distribution’s critical cutoff values. It measures the precise surface area of the true effect’s sampling distribution that gets obscured beneath the veil of the null hypothesis’s acceptance zone.

Directly coupled to the beta level is the foundational concept of statistical power, defined as the mathematical complement of beta:

Statistical Power = 1 − β = P(T(X) ∈ C | H₁(θ₁) is true) = ∫_C f(t | θ₁) dt

Statistical power quantifies the probability that a statistical test will correctly detect a genuine population effect of a specified magnitude, yielding a statistically significant result (p ≤ α). Whereas the alpha level is fixed purely by researcher decree prior to data collection, the realization of beta is governed by a functional interplay of four operational parameters:

• The Pre-Specified Alpha Level (α): As α becomes more stringent, the critical cutoff shifts into the distribution tail, increasing the non-rejection area under H₁, which mechanically inflates β.
• The True Population Effect Size (δ): The distance separating the null parameter θ₀ from the alternative parameter θ₁ (quantified via metrics like Cohen’s d, Pearson’s r, or odds ratios). Larger effect sizes displace the alternative sampling distribution further along the horizontal axis, pulling it out of the non-rejection region and driving β toward zero.
• The Sample Size (N): As sample size increases, the standard error of the sampling distribution contracts according to σ / √N. This sharpens both distributions, reducing their spatial overlap and dramatically depressing β.
• The Measurement Variance and Experimental Noise (σ²): Uncontrolled methodological error, low measurement reliability, and heterogeneous experimental units widen the standard error, driving the null and alternative distributions together and driving β upward.

3.2 Standard Conventions and Methodological Neglect

In the seminal contributions that structured contemporary power analysis, the pioneering statistician Jacob Cohen (1988) addressed the institutional void regarding beta conventions. Cohen observed that while researchers treated the α = .05 standard as an inviolable commandment, they routinely conducted research with complete disregard for the magnitude of beta. To establish a baseline framework for experimental planning, Cohen proposed a convention that has since become institutionalized throughout the empirical literature: setting the nominal target for statistical power at 80%, which corresponds to an allowable beta level of β = .20.

Cohen justified this specific benchmark through an explicit comparative heuristic regarding the perceived relative cost of inferential errors in fundamental behavioral research. Cohen posited that under typical academic research conditions, a Type I error (erroneously propagating an invalid theoretical claim) is generally viewed as four times more detrimental to the scientific enterprise than a Type II error (failing to discover a genuine theoretical effect). By establishing α = .05 and β = .20, Cohen formalized this 4:1 loss ratio:

Cost Ratio = β / α = 0.20 / 0.05 = 4

Under this normative framework, an investigator explicitly accepts that their experimental machinery will fail to detect an authentic underlying phenomenon twenty percent of the time, provided that their rate of generating spurious discoveries is constrained to five percent over the long run.

Despite Cohen’s prescriptive efforts, empirical surveys spanning decades of published research across psychology, neuroscience, ecology, and medicine demonstrate widespread methodological neglect of beta control. Studies consistently reveal that the median statistical power of published empirical literature rarely approaches the nominal 80% mark, frequently hovering around 50%, and in specialized subfields such as structural neuroimaging and animal behavioral models, often plunging below 20% to 30%. In such severely underpowered research regimes, the actual operative beta level escalates to catastrophic ranges between β = .50 and β = .80. This means that researchers are operating experimental protocols that are more likely to miss real phenomena than to identify them, effectively rendering the execution of empirical research an exercise in stochastic futility.

3.3 Practical Implications of Beta Selection

The practical, economic, and human consequences of failing to control the beta level are staggering. In biomedical research and clinical epidemiology, an inflated beta level translates directly into the premature abandonment of genuinely efficacious therapeutic interventions. Consider a Phase II randomized controlled trial evaluating a novel, low-toxicity oncology drug designed to extend patient survival. If the trial enrolls an insufficient number of patients, resulting in an operative power of only 40% (β = .60) for detecting a clinically meaningful hazard ratio, there is a 60% probability that the trial will yield a non-significant result (p > .05). Such a failure to achieve significance frequently leads pharmaceutical sponsors to terminate the development program, write off the research assets, and shelve the compound. In such scenarios, a compound that could have extended human lives is discarded, not because the underlying pharmacology failed, but because the experimental designers allowed beta to consume the trial.

Beyond the abandonment of specific interventions, chronic neglect of beta induces massive financial and operational waste. Executing large-scale clinical, sociological, or industrial experiments requires substantial capital, logistical deployment, and the recruitment of human participants who often undergo uncomfortable or risky procedures. When a study is designed with an operative beta level of .50, the capital invested is largely squandered on an uninformative coin flip. If the test returns a non-significant p-value, the scientific output is fundamentally ambiguous: the result could reflect the true absence of an effect, or it could simply reflect the study’s structural inability to resolve the signal from the background noise. This condition of inferential paralysis leads to endless cycles of inconclusive research that clog literature reviews without providing definitive empirical resolution.

Furthermore, pervasive high beta rates inflict subtle, systemic damage upon quantitative meta-analytic syntheses through the manifestation of “Type M” (magnitude / exaggeration) and “Type S” (sign) errors, as rigorously articulated by Andrew Gelman and John Carlin (2014). When the scientific literature operates under high beta levels, the only studies that manage to cross the stringent α = .05 significance barrier are those that, purely through stochastic sampling flukes, happen to yield wildly inflated effect sizes. When these rare, statistically significant outliers are subsequently compiled into meta-analyses, they systematically distort the estimated effect size upward, embedding distorted expectations into subsequent grant applications, therapeutic guidelines, and public policy initiatives.

4. Key Differences Between Alpha Level and Beta Level

4.1 Core Theoretical and Operational Disparities

To grasp the nuanced interplay between alpha and beta, one must dissect their core operational divergences across the mathematical, philosophical, and mechanical domains of statistical inference. At the most fundamental level, the alpha level and the beta level diverge in their target hypothesis assumptions. The calculation and operational verification of the alpha level requires assuming only the validity of a single, invariant, and often simple point null hypothesis (H₀: μ = 0). Under this null condition, the sampling distribution of the test statistic has a fixed, known mean of zero (or other specified baseline) and a dispersion determined entirely by the standard error. Consequently, alpha is uniquely stable and can be directly set by the investigator via the establishment of critical cutoff values on the reference distribution.

In stark contrast, the beta level can never be computed in the abstract against a generalized “non-null” condition. Beta exists only relative to a specific, mathematically parametrized alternative hypothesis (H₁: μ = δ). Because the true population effect size δ is almost never known in real-world empirical settings (if it were known with certainty, conducting the experiment would be redundant), beta is always an estimated, conditional parameter. An investigator cannot simply state, “The beta level of my experiment is .20,” without appending the vital qualifier, “for a postulated true population effect size of d = 0.50.” If the authentic effect size in nature happens to be d = 0.25, the true operative beta level of that exact same experiment immediately balloons to an entirely different, vastly higher value.

This operational divergence dictates how researchers control each parameter. Alpha is under the direct, unmediated control of the investigator at the moment of design execution; the researcher simply writes down “α = .05” or “α = .001” and identifies the corresponding critical value (e.g., z = 1.96 or 3.29). Beta, however, cannot be directly set by decree. Beta can only be indirectly manipulated through the calibration of external experimental levers: expanding the sample size (N), refining measurement precision to depress σ², utilizing within-subjects or matched-pairs designs to minimize variance, or artificially inflating the intervention’s strength to expand the true effect size δ. Controlling beta requires tangible logistical labor, funding, and structural design optimization, whereas controlling alpha requires only the theoretical determination of a mathematical cutoff point.

4.2 Methodological and Practical Dimensions

The structural divergences between alpha and beta translate into profoundly different practical roles across the scientific enterprise. Methodologically, alpha functions as the primary guardian of conservatism, designed to prevent the proliferation of spurious scientific claims and maintain institutional credibility against the chaos of false alarms. Beta, on the other hand, functions as the engine of scientific discovery and empirical sensitivity, designed to ensure that substantive, genuine phenomena are successfully detected, cataloged, and mobilized for theoretical progress or practical utility.

This division maps onto the conceptual terminology of diagnostic testing, epidemiology, and signal detection theory. Within diagnostic frameworks, the alpha level maps directly onto the complement of diagnostic specificity. Specificity, defined as the true negative rate, corresponds mathematically to 1 − α. A test with an alpha of .05 maintains a 95% specificity, successfully identifying healthy or non-affected cases 95% of the time. Conversely, the beta level maps onto the complement of diagnostic sensitivity. Sensitivity, defined as the true positive rate, corresponds precisely to statistical power (1 − β). An experiment with a beta level of .20 possesses an 80% sensitivity, successfully resolving genuine signals from background noise in eight out of ten instances.

To provide a clear, structured, and balanced comparison of these two foundational parameters, the following table delineates their primary differences across all relevant theoretical, mathematical, and operational dimensions:

Dimension / Aspect	Alpha Level (α)	Beta Level (β)
Error Classification	Type I Error: Probability of rejecting a true null hypothesis (False Positive / False Alarm).	Type II Error: Probability of failing to reject a false null hypothesis (False Negative / Missed Discovery).
Mathematical Formulation	α = P(Reject H0 | H0 is true) = ∫C f(t | θ0) dt	β = P(Fail to Reject H0 | H1 is true) = ∫Cc f(t | θ1) dt
Point of Control	Direct: Directly set by the researcher a priori via the selection of the critical region boundary.	Indirect: Modulated through sample size (N), effect size (δ), design efficiency, and alpha level.
Hypothesis Dependency	Requires assuming only a single point null hypothesis (H0: θ = θ0).	Inherently conditioned upon a specific, parameterized alternative hypothesis (H1: θ = θ1).
Diagnostic Counterpart	Complement of Specificity: Specificity = 1 − α (True Negative Rate).	Complement of Sensitivity: Sensitivity / Statistical Power = 1 − β (True Positive Rate).
Standard Disciplinary Benchmarks	Typically set at .05 or .01 in social/biomedical sciences; reaches 5-sigma (≈ 3 × 10−7) in physics.	Conventionally set at .20 (yielding 80% power) or .10 (90% power) per Cohen’s heuristics.
Scientific Consequence of Failure	Contaminates literature with phantom effects, prompting futile replication efforts and false paradigms.	Terminates promising therapeutic interventions, obscures genuine phenomena, and wastes research resources.
Behavior Under Increasing Sample Size (N)	Nominal threshold remains fixed at its preset value; empirical p-values decrease toward zero under H1.	Decreases exponentially toward zero (statistical power approaches 100%) for any non-zero effect size.
Historical Origin	Synthesized from Ronald A. Fisher’s significance testing framework and early agricultural experiments.	Formalized by Jerzy Neyman and Egon Pearson within statistical decision theory and power analysis.
Economic / Logistical Cost	Zero marginal cost to alter mathematically; setting a stricter alpha requires no immediate physical resources.	High marginal cost; reducing beta requires collecting larger samples, deploying more precise instruments, or extending trials.

As the table above illustrates, neither parameter can be evaluated in isolation. While the alpha level acts as an administrative firewall protecting the body of scientific knowledge from unwarranted claims, the beta level serves as the empirical bridge determining whether real-world signals ever cross into scientific visibility.

5. Mathematical and Theoretical Overlap Between Alpha and Beta

5.1 The Hydraulic Relationship and Inherent Trade-Off

The relationship between alpha and beta is fundamentally hydraulic: when the physical dimensions of an empirical experiment (specifically, its sample size N and the underlying population effect size δ) are held static, pushing down on the probability of a Type I error (α) forces the probability of a Type II error (β) to rise, and vice versa. This dynamic is not an arbitrary feature of institutional research guidelines, but an inescapable geometric consequence of partitioning continuous probability density functions across a shared horizontal domain.

To visualize this mathematically, consider a one-tailed continuous z-test designed to evaluate whether a population mean μ is greater than zero under a known population standard deviation σ = 1. The null hypothesis specifies H₀: μ = 0, under which the sample mean distribution is centered at 0 with standard error SE = 1 / √N: Z ~ N(0, 1 / N). The alternative hypothesis specifies a true population shift H₁: μ = δ > 0, under which the sample distribution is centered at δ with the identical standard error: Z ~ N(δ, 1 / N). The critical decision boundary k along the real number line is established uniquely by the pre-selected alpha level:

k = 0 + z_{1 − α} × (1 / √N)

The rejection region comprises all values to the right of k, while the non-rejection region comprises all values to the left of k. The beta level represents the area of the alternative distribution N(δ, 1 / N) that falls into this non-rejection region (to the left of k). Mathematically, beta is expressed via the standard normal cumulative distribution function Φ as:

β = Φ((k − δ) / (1 / √N)) = Φ(z_{1 − α} − δ√N)

From this equation, the hydraulic coupling becomes obvious. If an investigator decides to make their alpha level more stringent—for instance, shifting from α = .05 (where z_.95 = 1.645) to α = .001 (where z_.999 = 3.090)—the critical threshold k shifts substantially to the right. Because δ and N are fixed, the argument inside the cumulative normal function (z_{1 − α} − δ√N) increases. Because Φ is a strictly monotonically increasing function, β increases directly. By choosing to suppress the false alarm rate, the researcher has moved the goalposts deeper into the tail of the alternative distribution, ensuring that a vast proportion of the true effect’s distribution now sits on the “fail to reject” side of the cutoff.

This mathematical reality proves that within any finite, fixed-sample probabilistic design, it is fundamentally impossible to simultaneously minimize both Type I and Type II errors to zero. The researcher cannot eliminate risk; they can only redistribute risk between two competing failure states. Every decision to enforce hyper-skepticism against false positive claims carries an exact, quantifiable mathematical penalty in the form of elevated blindness to true discoveries.

5.2 Shared Influencing Parameters

While alpha and beta stand in an inverse hydraulic relationship under static conditions, they are governed by a shared set of underlying statistical parameters that can shift the entire system. Understanding these shared levers reveals how an experimental designer can bypass the zero-sum trade-off and achieve simultaneous reductions in both α and β.

The primary master leverage point capable of shrinking both error probabilities concurrently is the sample size (N). In the equation for beta derived above, β = Φ(z_{1 − α} − δ√N), the term √N functions as a scaling factor directly multiplied by the effect size δ. As N expands toward infinity, the standard error (σ / √N) contracts toward zero. In geometric terms, increasing N compresses the spread of both the null distribution and the alternative distribution, turning wide, overlapping bell curves into narrow, razor-sharp spikes. As the distributions compress, their physical overlap diminishes exponentially. Consequently, an investigator who commands a massive sample size can simultaneously declare an ultra-stringent alpha level (e.g., α = .001) while still driving beta down to near zero (β < .01), achieving high specificity and sensitivity simultaneously.

The second shared parameter is the underlying effect size (δ). In standardized metrics such as Cohen’s d = (μ₁ − μ₂) / σ, the effect size quantifies the physical separation between the centers of the two distributions relative to their standard deviation. When the true population effect is immense (e.g., penicillin for treating severe bacterial infections, where d > 3.0), the null and alternative distributions are pushed so far apart along the real number line that virtually no overlapping area exists between them. Under such conditions, even small samples yield negligible alpha and beta levels; the signal towers over the noise. Conversely, when investigating subtle, polygenic psychological traits or minor economic nudges where d ≈ 0.10, the two distributions are nearly superimposed, turning the hydraulic conflict between alpha and beta into an acute methodological crisis.

The third shared parameter is experimental noise and measurement unreliability. The total standard deviation σ governing the standard error represents a compound of true biological/sociological population variance (σ²_true) and extraneous measurement error (σ²_error). When investigators utilize psychometrically invalid questionnaires, noisy laboratory instruments, poorly standardized protocols, or heterogeneous convenience samples, σ²_error expands. This expands the overall variance, broadening the sampling distributions and maximizing their spatial overlap. High experimental noise simultaneously inflates the empirical instability of alpha and elevates beta across all anticipated effect sizes. Methodological rigor, psychometric precision, and environmental control act as variance-reduction mechanisms that separate the distributions, providing statistical leverage identical to an expansion in sample size.

6. When to Prioritize Alpha vs. Beta: Decision Frameworks

6.1 Scenarios Demanding Strict Alpha Control

The absolute prioritization of the alpha level over the beta level is warranted whenever the tangible, societal, economic, or scientific costs of committing a Type I error are substantially more catastrophic than the costs of committing a Type II error. In such asymmetric cost regimes, the empirical machinery must be calibrated to function as a hyper-skeptical fortress, demanding an overwhelming burden of proof before any null hypothesis is rejected.

A primary domain demanding strict alpha control is confirmatory late-stage clinical trials (Phase III), particularly when evaluating therapeutic interventions that entail severe toxicities, invasive surgical procedures, or significant economic costs. If an oncology drug causes severe cardiac toxicity and costs $100,000 per treatment course, falsely concluding that this drug extends cancer survival when it is biologically inactive (a Type I error) would be disastrous. Patients would be subjected to debilitating adverse events, families would be financially devastated, and public healthcare systems would waste limited resources on an ineffective therapy. Under such stakes, regulatory bodies enforce strict alpha thresholds (e.g., α = .01 or independent replication at α = .025), accepting a higher beta risk (the possibility that a marginally effective compound goes unapproved) to prevent poisoning or bankrupting patients with ineffective treatments.

A second clear domain is forensic science and criminal jurisprudence. The Anglo-American legal maxim formalized by William Blackstone—that “it is better that ten guilty persons escape than that one innocent suffer”—is a direct, non-mathematical expression of extreme alpha prioritization. Within forensic genomics, toxicological analysis, and biometric identification used in criminal prosecutions, the null hypothesis posits that the suspect is innocent (or that the biological sample does not match the defendant). A Type I error represents convicting an innocent individual, stripping them of liberty or life. A Type II error represents failing to convict a guilty individual. Because society views the state execution or wrongful incarceration of an innocent person as an unacceptable moral catastrophe, forensic identification procedures mandate hyper-conservative alpha thresholds, requiring statistical certainty exceeding one in billions before a forensic match is admissible in court.

A third scenario involves high-throughput exploratory science and genomics. In modern scientific architectures such as Genome-Wide Association Studies (GWAS), mass spectrometry proteomics, and functional neuroimaging (fMRI), computers execute hundreds of thousands or millions of simultaneous significance tests across a single biological sample. If an investigator maintained a standard alpha of α = .05 across a GWAS testing 1,000,000 single nucleotide polymorphisms (SNPs), the test would generate approximately 50,000 false positive associations by chance alone, completely flooding the scientific literature with noise. Here, strict alpha control is mathematically imperative. The field routinely enforces genome-wide significance thresholds of α = 5 × 10⁻⁸, deliberately absorbing a massive Type II error penalty (failing to identify subtle genetic associations) to preserve the integrity of the confirmed target pool.

6.2 Scenarios Demanding Strict Beta Control

Conversely, the systematic prioritization of the beta level over the alpha level is mandatory whenever the cost of missing an authentic phenomenon (Type II error) is vastly more severe than the cost of investigating a false alarm (Type I error). In these scenarios, the experimental apparatus must function as an ultra-sensitive radar, designed to capture every possible signal, even at the expense of sweeping up considerable stochastic noise.

The most acute manifestation of this paradigm occurs in early-stage disease screening and public health diagnostics. Consider the deployment of a diagnostic assay for a highly lethal, highly infectious pathogen (such as Ebola, HIV, or novel pandemic strains) or early-stage screening for asymptomatic, aggressive malignancies (such as pancreatic or ovarian cancer). In this context, the null hypothesis specifies that the patient is healthy. A Type I error leads to a false positive screening result: the patient undergoes anxiety and is referred for confirmatory diagnostic testing (such as a biopsy or quantitative PCR). A Type II error, however, means issuing a clean bill of health to an infected or malignant individual. That patient will receive no medical treatment, will miss the window for early intervention, and may succumb to the illness while spreading contagion through the population. Consequently, diagnostic screening tests are intentionally engineered with loose alpha levels to achieve near-zero beta levels (β < .01, yielding sensitivities exceeding 99%). The downstream system relies on subsequent confirmatory tests to filter out the resulting false alarms.

A second critical domain is safety-critical industrial engineering, aerospace monitoring, and nuclear safety systems. In the monitoring architectures of nuclear reactor cooling loops or commercial airliner fly-by-wire avionics, sensor arrays continuously run automated inferential tests evaluating whether thermal, vibrational, or pressure metrics deviate from normal operating baselines. A Type I error causes a false alarm: an automated maintenance warning is tripped, an engine is manually inspected, or a system safely shuts down temporarily, incurring moderate operational costs. A Type II error, however, represents the undetected failure of a primary flight control surface or reactor cooling line, resulting in catastrophic structural failure and massive loss of life. Modern safety-critical engineering completely subordinates alpha control to beta minimization; systems are designed with high sensitivity to ensure that any potential structural anomaly is flagged instantly.

A third vital academic scenario involves early-phase exploratory drug discovery and pilot studies. In Phase I/IIa preclinical drug screening, research teams evaluate thousands of chemical compounds to determine which molecules exhibit target binding or cellular inhibition. If a researcher enforces a hyper-conservative alpha level (e.g., α = .001) during this exploratory phase, they will inevitably induce an immense beta level, prematurely discarding dozens of viable compounds that possessed genuine therapeutic utility. In exploratory screening, the cost of a false positive is merely running an inexpensive follow-up secondary assay, whereas the cost of a false negative is the total, permanent loss of a potential multi-billion-dollar therapeutic breakthrough. Methodologists routinely recommend relaxing exploratory alpha levels to α = .10 or .20 to drive beta down toward .05, ensuring that true therapeutic candidates are not discarded at the initial gate.

6.3 Cost-Benefit Optimization and Custom Loss Functions

The historic practice of uncritically adopting default alpha and beta thresholds (α = .05, β = .20) represents an intellectual shortcut that ignores the actual real-world stakes of empirical decision-making. Pioneering methodologists in statistical decision theory, such as Jacob Cohen (1992) and modern open-science reformers such as Daniel Lakens et al. (2018), have repeatedly advocated for abandoning arbitrary conventions in favor of formal cost-benefit optimization models utilizing explicit economic and societal loss functions.

To construct a custom loss function, an investigator must explicitly quantify the tangible utility or financial/societal penalties associated with each of the four possible outcomes in the inferential decision matrix:

• C_I: The tangible cost or loss associated with committing a Type I error (False Positive).
• C_II: The tangible cost or loss associated with committing a Type II error (False Negative).
• U_{Correct Null}: The baseline utility gained by correctly retaining a true null hypothesis.
• U_{Correct Discovery}: The baseline utility gained by correctly discovering a true effect.

Furthermore, this formal decision model incorporates the pre-study prior probability (base rate) that the alternative hypothesis is true, denoted as P(H₁) = π, which means the prior probability of the null hypothesis is P(H₀) = 1 − π. The total expected loss (EL) of an experimental design can be mathematically articulated as:

EL(α, β) = (1 − π) × α × C_I + π × β × C_II

Under this decision-theoretic formulation, the optimal critical threshold for a study is not an arbitrary Fisherian .05 or Cohenian .20. The optimal threshold is the specific mathematical value of α (and its hydraulically paired β) that minimizes the total expected loss function EL. If an empirical audit reveals that a Type I error costs $1,000,000 (e.g., funding a failed multi-center Phase III trial based on bad preliminary data) while a Type II error costs $10,000 (e.g., re-running an inexpensive cell culture assay), the ratio of costs is C_I / C_II = 100:1. The researcher should select an alpha level that is substantially more stringent than beta, driving alpha into fractional percentages while allowing beta to absorb the residual uncertainty. Conversely, if a Type II error costs human lives while a Type I error causes minor administrative inconvenience, the ratio inverts, and the mathematics demands that β be prioritized over α.

By moving to custom loss functions, the scientific enterprise replaces dogmatic ritual with rational decision theory. Researchers are forced to transparently justify their selected error parameters based on the physical, economic, and moral stakes of their specific empirical domain, restoring the decision-theoretic framework originally envisioned by Neyman and Pearson.

7. Frequently Asked Questions

7.1 Can Alpha and Beta Be Equal in an Experimental Design?

Yes, alpha and beta can be configured to be precisely equal in an experimental design, and in many high-stakes operational environments, setting α = β represents the only rational, methodologically sound strategy. The widespread historical asymmetry where alpha is set to .05 and beta is set to .20 (a 4:1 loss ratio) is purely a sociological convention derived from basic behavioral research; it carries no foundational status in mathematical probability. Whenever an objective evaluation reveals that the societal, scientific, or financial consequences of committing a Type I error are identical to those of committing a Type II error (that is, C_I = C_II), symmetric error calibration becomes a mathematical imperative.

A classic domain where α and β are frequently balanced is industrial quality control and consumer-producer acceptance sampling. Consider a manufacturing facility producing high-precision semiconductor wafers or advanced composite structural components for commercial aviation. In statistical quality control testing, the null hypothesis posits that a manufacturing batch meets operational specifications. A Type I error rejects a perfectly manufactured batch, forcing the producer to scrap or re-manufacture flawless inventory at immense economic expense (Producer’s Risk). A Type II error ships a defective batch to the client, leading to downstream mechanical assembly failures, breach-of-contract penalties, and warranty liabilities (Consumer’s Risk). If the accounting audit reveals that the economic damage of scrapping good inventory precisely equals the contractual liability of shipping defective units, the manufacturer deliberately engineers their acceptance sampling protocol such that α = β = .05 (or α = β = .01).

Achieving parity between alpha and beta at high levels of confidence requires substantial sample sizes. For example, if a researcher evaluating an educational intervention targeting a medium effect size (Cohen’s d = 0.50) decides that missing a true educational improvement is just as harmful as implementing an ineffective curriculum (α = β = .05, meaning 95% statistical power), a standard two-tailed independent-samples t-test requires approximately N = 105 participants per group (210 total). By contrast, under the conventional Cohen standard (α = .05, β = .20), the researcher would only need N = 64 participants per group. Setting α = β = .05 demands an approximate 64% expansion in total sample size, illustrating why resource-constrained researchers frequently sacrifice beta parity to cut costs.

7.2 How Does Increasing Sample Size Affect Alpha and Beta Differently?

Increasing the sample size (N) exerts fundamentally different mathematical effects on the nominal alpha level versus the operative beta level of an experiment. The nominal alpha level is a fixed mathematical criterion selected by the investigator prior to data collection; therefore, by definition, the nominal alpha level does not change as sample size increases. If an investigator sets α = .05 for a study with N = 20 and maintains α = .05 for a study with N = 20,000, the probability of rejecting the null hypothesis under the assumption that the null hypothesis is strictly true remains exactly 5% in both cases.

What changes under an expanding sample size is the precision of the standard error (σ / √N), which fundamentally alters the behavior of empirical p-values and drives the beta level down exponentially. Because standard error contracts in inverse proportion to the square root of N, the sampling distribution of the test statistic under any non-zero alternative hypothesis H₁ narrows and shifts farther away from the null distribution’s critical cutoff. Consequently, for any fixed population effect size δ ≠ 0 and any pre-specified alpha level, increasing N causes the operative beta level to decrease exponentially toward zero, which is mathematically equivalent to statistical power (1 − β) converging asymptotically toward 1.0 (or 100%).

This differential behavior creates a profound operational advantage for well-funded research programs. When an investigator commands the logistical resources to recruit vast sample sizes, they are no longer trapped within the zero-sum hydraulic trade-off that constrains small-sample research. With large sample sizes, the researcher possesses sufficient statistical leverage to simultaneously dial down the nominal alpha level (e.g., moving from .05 to .005 or .001) to protect against false positive claims, while still driving the beta level downward (e.g., maintaining β < .05, or power > 95%). Massive sample sizes give researchers the mathematical freedom to suppress both failure modes at the same time.

7.3 What Is the Relationship Between Beta and Statistical Power?

The relationship between the beta level and statistical power is one of direct mathematical complementarity. Statistical power is formally defined as:

Statistical Power = 1 − β

Because they are mathematical complements within the domain of the alternative hypothesis H₁, statistical power and beta sum to unity (Power + β = 1.0). If an experiment is designed with a beta level of β = .15, its statistical power is precisely 1 − .15 = .85 (or 85%). If the beta level rises to β = .40, the statistical power drops to 60%. There is no mathematical distinction between discussing the minimization of Type II error risk and discussing the maximization of statistical power; they are simply the negative and positive descriptions of the exact same underlying sampling reality.

Conceptually, while beta represents the risk of an empirical failure (the probability of a false negative), statistical power represents the rate of empirical success: the probability that an experiment will yield a statistically significant result (p ≤ α) when a true population effect of a specified magnitude actually exists. Power measures the resolving capability of an experimental apparatus. Just as an optical telescope with insufficient aperture cannot resolve distant binary stars from background darkness, an experimental design with insufficient statistical power (high beta) cannot resolve genuine biological or psychological effects from stochastic sampling noise.

Across modern empirical disciplines, the consensus regarding minimum acceptable power standards has undergone substantial revision. While Cohen’s historical 80% power benchmark (β = .20) remains the nominal baseline in introductory textbooks, modern methodological authorities widely advocate for targeting minimum power levels of 90% (β = .10) or 95% (β = .05) in confirmatory research. As demonstrated by Jacob Cohen (1994) and subsequent replication researchers, an 80% power target still leaves a one-in-five chance of missing real phenomena. When independent laboratories attempt to replicate a landmark finding using studies powered at only 80%, the joint probability of two successive studies both achieving statistical significance is only 0.80 × 0.80 = 0.64 (64%), meaning that more than one-third of genuine scientific breakthroughs will artificially “fail” replication simply due to standard beta allowances.

8. Conclusion: Synthesizing Alpha and Beta for Robust Statistical Inference

8.1 Summary of Comparative Takeaways

The alpha level and the beta level represent the two fundamental axes of inferential risk within quantitative hypothesis testing. The alpha level serves as the gatekeeper against Type I errors, establishing an institutional threshold of skepticism designed to prevent the proliferation of false discoveries. The beta level governs the vulnerability to Type II errors, quantifying the probability that authentic population effects will remain undetected. Statistical power (1 − β) serves as the empirical engine of scientific research, dictating the practical sensitivity of an investigation to identify genuine discoveries.

Crucially, alpha and beta are linked through an unavoidable hydraulic relationship. Under static experimental conditions with fixed sample sizes and effect sizes, reducing one error probability inherently inflates the other. The only mechanisms capable of breaking this zero-sum constraint are the systematic expansion of sample size (N) and the reduction of measurement and experimental noise. Consequently, researchers must move beyond the historical habit of uncritically relying on arbitrary default thresholds, such as Fisher’s .05 alpha or Cohen’s .20 beta. These historical benchmarks reflect specific sociological compromises of mid-twentieth-century research rather than universal mathematical truths.

The comparative evaluation of alpha versus beta reveals that neither metric is inherently superior. Over-prioritizing alpha produces a hyper-skeptical regime characterized by missed therapeutic opportunities and intellectual conservatism. Over-prioritizing beta floods the scientific ecosystem with spurious claims and unreplicable findings. Methodological maturity requires researchers to balance both parameters against the empirical, financial, and ethical consequences of each specific scientific inquiry.

8.2 Best Practices for Modern Research Design

To establish a reproducible, methodologically rigorous scientific practice, contemporary researchers should implement several core operational reforms:

• Mandatory Prospective Power and Sensitivity Analyses: Empirical investigations should never be launched without formal, a priori power calculations. Researchers must explicitly specify their target effect size, justify why that effect size is theoretically or practically meaningful, and identify the exact sample size (N) required to achieve their chosen beta level. If logistical constraints cap the maximum obtainable sample size, researchers should conduct a sensitivity power analysis to determine the smallest effect size their design can reliably detect.
• Explicit Preregistration of Error Parameters: To eliminate post-hoc analytical adjustments and p-hacking, investigators should preregister their complete statistical analysis plans on public repositories. Preregistrations must document the nominal alpha level, planned adjustments for multiple comparisons, and designated beta targets before data collection begins.
• Contextual Error Calibration via Custom Loss Functions: Rather than reflexively defaulting to α = .05 and β = .20, researchers should explicitly evaluate the relative costs of Type I and Type II errors within their specific domain. In early-stage exploratory research, alpha thresholds should be strategically relaxed to suppress beta; in high-stakes confirmatory trials, alpha should be prioritized to prevent false alarms.
• Comprehensive Reporting of Effect Sizes and Confidence Intervals: Authors and journals must transition away from presenting binary significance verdicts (significant vs. non-significant) in isolation. Every empirical test should be accompanied by point estimates of effect size (e.g., Cohen’s d, Pearson’s r, odds ratios) and their associated confidence intervals. Confidence intervals contextualize both alpha and beta by showing the precision of the estimate, preventing non-significant findings from being misinterpreted as proof of no effect.
• Publishing High-Powered Null Findings: Scientific journals must dismantle publication biases that favor statistically significant results. A well-designed, highly powered study (β ≤ .05) that fails to reject the null hypothesis provides valuable scientific information, establishing that the postulated effect size is exceedingly unlikely to exist in nature.

By treating the alpha level and the beta level as complementary, mathematically coupled dials rather than unexamined historical defaults, the scientific community can build a more transparent, efficient, and reproducible inferential architecture capable of serving the demands of modern empirical discovery.

References

• Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Methodological), 57(1), 289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x
• Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Lawrence Erlbaum Associates. https://doi.org/10.4324/9780203771587
• Cohen, J. (1992). A power primer. Psychological Bulletin, 112(1), 155–159. https://doi.org/10.1037/0033-2909.112.1.155
• Cohen, J. (1994). The earth is round (p < .05). American Psychologist, 49(12), 997–1003. https://doi.org/10.1037/0003-066X.49.12.997
• Fisher, R. A. (1925). Statistical Methods for Research Workers. Oliver and Boyd. https://doi.org/10.1007/978-1-4612-4380-9
• Gelman, A., & Carlin, J. (2014). Beyond power calculations: Assessing Type S (sign) and Type M (magnitude) errors. Perspectives on Psychological Science, 9(6), 641–651. https://doi.org/10.1177/1745691614551642
• Greenland, S., Senn, S. J., Rothman, K. J., Carlin, J. B., Poole, C., Goodman, S. N., & Altman, D. G. (2016). Statistical tests, P values, confidence intervals, and power: A guide to misinterpretations. European Journal of Epidemiology, 31(4), 337–350. https://doi.org/10.1007/s10654-016-0149-3
• Ioannidis, J. P. A. (2005). Why most published research findings are false. PLOS Medicine, 2(8), e124. https://doi.org/10.1371/journal.pmed.0020124
• Lakens, D., Adolfi, F. G., Albers, C. J., Anvari, F., Apps, M. A., Argamon, S. E., Baguley, T., Becker, R. B., Ben-Shachar, M. S., Bicknell, K., Blasiman, R., Bodner, G. E., Botella, J., Bousfield, G., Brauer, M., Brysbaert, M., Burt, C. D., Cattaneo, Z., Cedervall, B., … Zwaan, R. A. (2018). Justify your alpha. Nature Human Behaviour, 2(3), 168–171. https://doi.org/10.1038/s41562-017-0189-z
• Neyman, J., & Pearson, E. S. (1928). On the use and interpretation of certain test criteria for purposes of statistical inference: Part I. Biometrika, 20A(1/2), 175–240. https://doi.org/10.2307/2331945
• Neyman, J., & Pearson, E. S. (1933). On the problem of the most efficient tests of statistical hypotheses. Philosophical Transactions of the Royal Society of London. Series A, Containing Papers of a Mathematical or Physical Character, 231(694-706), 289–337. https://doi.org/10.1098/rsta.1933.0009